Kaempferol Attenuates LPS-Induced Striatum Injury in Mice Involving Anti-Neuroinflammation, Maintaining BBB Integrity, and Down-Regulating the HMGB1/TLR4 Pathway

Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4/MyD88 pathway

(2018) Xiao Cheng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches

(2018) Efthalia Angelopoulou et al.   JOURNAL OF NEUROCHEMISTRY

3D imaging of PSD-95 in the mouse brain using the advanced CUBIC method

(2018) Huazheng Liang et al.   Molecular Brain

Astragalus Polysaccharide Protects Neurons and Stabilizes Mitochondrial in a Mouse Model of Parkinson Disease

(2018) Hong Liu et al.   MEDICAL SCIENCE MONITOR

Ginsenoside Rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction

(2017) Junyi Shen et al.   International Journal of Nanomedicine

Parkinsons disease in the older patient

(2016) S. J. Lewis et al.   CLINICAL MEDICINE

Dichotomous Life of DNA Binding High Mobility Group Box1 Protein in Human Health and Disease

(2016) Neelam Lohani et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease

(2016) Tatsuya Sasaki et al.   EXPERIMENTAL NEUROLOGY

In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin

(2016) Matteo Santoro et al.   NEUROBIOLOGY OF DISEASE

Curcumin alleviates brain edema by lowering AQP4 expression levels in a rat model of hypoxia-hypercapnia-induced brain damage

(2016) LIN-SHENG YU et al.   Experimental and Therapeutic Medicine

Effects of Paeonol on Anti-Neuroinflammatory Responses in Microglial Cells

(2015) Chingju Lin et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Dysfunction of brain pericytes in chronic neuroinflammation

(2015) Yuri Persidsky et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease

(2015) Madison T Gray et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Kaempferol, a potential cytostatic and cure for inflammatory disorders

(2014) Peramaiyan Rajendran et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Monocyte chemoattractant protein-1 and the blood–brain barrier

(2013) Yao Yao et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s Disease

(2013) Sandeep Vasant More et al.   MEDIATORS OF INFLAMMATION

RAGE and TLRs: Relatives, friends or neighbours?

(2013) Zaridatul Aini Ibrahim et al.   MOLECULAR IMMUNOLOGY

Unknown

(2012) Hulda Hreggvidsdottir et al.   MOLECULAR MEDICINE

Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons

(2011) Nadia Stefanova et al.   AMERICAN JOURNAL OF PATHOLOGY

Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

(2011) F. Ros-Bernal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Microglial activation and chronic neurodegeneration

(2010) Melinda E. Lull et al.   Neurotherapeutics

Parkinson's disease

(2009) Andrew J Lees et al.   LANCET

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

(2009) Etienne C Hirsch et al.   LANCET NEUROLOGY

Severe Blood–Brain Barrier Disruption and Surrounding Tissue Injury

(2009) Bo Chen et al.   STROKE

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease

(2008) Vanessa Brochard et al.   JOURNAL OF CLINICAL INVESTIGATION